The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

10051–10075 of 11860

  • SevereFDA (Drugs)·D-1460-2014·2014-07-30

    Trinity Care Solutions Recalls Invanz Due to Sterility Concerns

    Trinity Care Solutions is recalling 12 units of compounded Invanz in Florida due to quality control concerns regarding sterility assurance identified during an FDA inspection.

    Product
    Invanz (ertapenem)1 gm/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29157, Discard After 05/19/14; Rx # 29097, Discard After 05/20/14
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1482-2014·2014-07-30

    Trinity Care Solutions Recalls Ceftriaxone Due to Sterility Concerns

    Trinity Care Solutions is recalling 12 units of Ceftriaxone 1 gm/50 mL D5W in Florida due to quality control concerns identified during an FDA inspection.

    Product
    Ceftriaxone 1 gm/50 mL D5W, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29190, Discard After 05/23/14, Rx # 29068, Exp 05/18/14
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1477-2014·2014-07-30

    Trinity Care Solutions Recalls Compounded Cubicin Due to Sterility Concerns

    Trinity Care Solutions is recalling 8 units of compounded Cubicin 600 mg/100 mL due to quality control concerns regarding sterility assurance.

    Product
    Cubicin 600 mg/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29096, Discard After 05/20/14
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1480-2014·2014-07-30

    Trinity Care Solutions Recalls Ceftriaxone Due to Sterility Concerns

    Trinity Care Solutions is recalling 5 units of Ceftriaxone 2 gm/100 mL D5W due to quality control concerns identified during an FDA inspection.

    Product
    Ceftriaxone 2 gm/100 mL D5W, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29150, Discard After 05/17/14
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1481-2014·2014-07-30

    Trinity Care Solutions Recalls Cefepime Due to Sterility Concerns

    Trinity Care Solutions is recalling 11 units of Cefepime 2 gm/100 mL 0.9%NS due to quality control concerns identified during an FDA inspection.

    Product
    Cefepime 2 gm/100 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 28879, Discard After 05/21/14
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1468-2014·2014-07-30

    Trinity Care Solutions Recalls Normal Saline Syringes Due to Sterility Concerns

    Trinity Care Solutions is recalling Normal Saline 10 mL syringes in Florida due to quality control concerns identified during an FDA inspection.

    Product
    Normal Saline 10 mL/10 mL Syringe, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, Rx # 28839, Discard After 05/5/15; Rx # 29163, Discard After 05/8/15
    Category
    Medical Device
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1470-2014·2014-07-30

    Trinity Care Solutions Recalls ANA Kit Due to Sterility Concerns

    Trinity Care Solutions is recalling ANA Kits due to quality control concerns identified during an FDA inspection regarding the assurance of sterility.

    Product
    ANA Kit, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 28838, Discard After 03/4/15
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-1442-2014·2014-07-23

    CareFusion Recalls ChloraPrep Applicators Due to Sterility Concerns

    CareFusion is recalling 23,000 ChloraPrep applicators because immediate product pouches may not be properly sealed, potentially compromising sterility.

    Product
    ChloraPrep With Tint, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA), 26 mL APPLICATOR, Hi-Lite Orange. Rx Only. CareFusion, El Paso, TX 79912. NDC: 054365-400-13.
    Category
    Medical Device
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1433-201·2014-07-23

    Hospira Recalls Fentanyl Citrate Injection Due to Sterility Concerns

    Hospira is recalling 47,400 vials of Fentanyl Citrate Injection because loose or missing vial crimps raise concerns about sterility.

    Product
    FENTANYL CITRATE — FENTANYL CITRATE (FENTANYL CITRATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1425-2014·2014-07-16

    Hospira Recalls Heparin Sodium Bags Due to Sterility Concerns

    Hospira is recalling 142,152 bags of Heparin Sodium in 5% Dextrose Injection due to a confirmed report of fluid leaking from the primary container, which compromises sterility.

    Product
    HEPARIN SODIUM AND DEXTROSE — HEPARIN SODIUM AND DEXTROSE (HEPARIN SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1424-2014·2014-07-16

    Hospira Recalls Labetalol Hydrochloride Injection Due to Particulate Matter

    Hospira Inc. is recalling Labetalol Hydrochloride Injection due to the presence of particulate matter, including metal embedded in glass vials and visible particles in the solution.

    Product
    LABETALOL HYDROCHLORIDE — LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1408-2014·2014-07-02

    Teva Recalls Dextroamphetamine Sulfate Tablets Due to Impurity Test Failures

    Teva Pharmaceuticals is recalling 9,882 bottles of Dextroamphetamine Sulfate 10 mg tablets because stability testing revealed out-of-specification impurities.

    Product
    DEXTROAMPHETAMINE SULFATE — DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1407-2014·2014-07-02

    Caraco Recalls Gemcitabine Injection Due to Sterility Assurance Concerns

    Caraco Pharmaceutical Laboratories is recalling 200 vials of Gemcitabine For Injection USP due to a lack of assurance of sterility.

    Product
    Gemcitabine For Injection USP, 1 g, (lyophilized), For Intravenous Use Only, Sterile Single Use Vial, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd, Gujarat, India, NDC 47335-154-40
    Category
    Drug
    Distribution
    1 state
  • HighFDA (Drugs)·D-1409-2014·2014-07-02

    Pfizer Recalls Pristiq 50 mg Tablets Due to Foreign 100 mg Tablet

    Pfizer is recalling Pristiq 50 mg extended-release tablets because a 100 mg tablet was found in a bottle labeled for 50 mg.

    Product
    PRISTIQ — PRISTIQ (DESVENLAFAXINE SUCCINATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1398-2014·2014-06-25

    John W Hollis Inc Recalls B-Complex/Adenosine Injectable Solution for Sterility Concerns

    John W Hollis Inc is recalling B-Complex/Adenosine Injectable Solution due to a lack of sterility assurance in the compounded aseptically filled products.

    Product
    B-Complex/Adenosine Inj sol, Adenosine-5-Monophosphate 0.03g, Choline Chloride 0.01g, Cyanocobalamin 0.3mg, Inositol 0.05g, Methionine 0.015g, Levocarnitine 0.1g, Chromic Chloride 0.15g, Lidocaine HCl 0.01g, Pyrodoxine HCl 0.005g, 30 mL, JOHN HOLLIS Pharmacist, Inc, 110 20th Aven
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1401-2014·2014-06-25

    John W Hollis Inc Recalls Compounded Injectable Drug Due to Sterility Concerns

    John W Hollis Inc is recalling a compounded injectable drug product due to a lack of assurance of sterility. The product is distributed nationwide.

    Product
    Papaverine HCl 30 mg, Phentolamine Mesylate 2 mg, Alprostadil 20 mcg, 10 mL, JOHN HOLLIS Pharmacist, Inc 110 20th Avenue N, Nashville, TN 37203, 615-327-3234
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1406-2014·2014-06-25

    John W Hollis Recalls Polidocanol 1% Injection Due to Sterility Concerns

    John W Hollis Inc. is recalling Lot 2868 of Polidocanol 1% Solution for Injection because the company cannot ensure the product is sterile.

    Product
    Polidocanol 1% Solution for Injection, each mL contains Polidocanol (Laureth 9) 10 mg, also contains Sterile Water for Injection, Ethyl Alcohol, Anhydrous Chlorobutanol, 50 mL, JOHN HOLLIS Pharmacist, Inc. 110 B2 Avenue N, Nashville, TN 37203, 615-327-3234
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1393-2014·2014-06-25

    John W Hollis Inc Recalls MIC Plus B12 Injectable Due to Sterility Concerns

    John W Hollis Inc is recalling MIC Plus B12 injectable vials because the products lack assurance of sterility. Consumers should stop using the affected lots immediately.

    Product
    MIC PLUS B12, Adenosine, L-Carnitine, Contains: Methionine 15mg, Choline 100mg, Inositol 50mg, B 12, 0.200mg, Adenosine 20mg, L-Carnitine 30mg/ML, 30ML MULTI DOSE VIAL, BENZYL ALCOHOL AS A PRESERVATIVE, JOHN HOLLIS Pharmacist, Inc, 110 20th Avenue N, Nashville, TN 37203, 615-32
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1395-2014·2014-06-25

    John W Hollis Recalls Levocarnitine Injection Due to Sterility Concerns

    John W Hollis Inc. is recalling Levocarnitine Solution for injection because the company cannot ensure the product is sterile. The recall covers specific lots distributed nationwide.

    Product
    Levocarnitine Solution for injection, l-Carnitine 50 mg, Also Contains Sterile Water for Injection and Benzyl Alcohol pH adjusted with HCl, 50 mL, JOHN HOLLIS Pharmacist, Inc. 110 20th Avenue N, Nashville, TN 37203, 615-327-3234
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1391-2014·2014-06-25

    John W Hollis Recalls Polidocanol 5% Injection Due to Sterility Concerns

    John W Hollis Inc is recalling Polidocanol 5% Solution for Injection because the company cannot ensure the product is sterile.

    Product
    Polidocanol 5% Solution for Injection, each mL contains Polidocanol (Laureth 9) 50 mg, also contains Sterile Water for Injection, Ethyl Alcohol, Anhydrous Chlorobutanol, 50 mL Vial, JOHN HOLLIS Pharmacist Inc, Inc. 110 20th Avenue N, Nashville, TN 37203, 615-327-3234
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1390-2014·2014-06-25

    John W Hollis Inc Recalls Cyanocobalamin Injection Due to Sterility Concerns

    John W Hollis Inc is recalling specific lots of Cyanocobalamin injection because the products lack assurance of sterility. The recall covers 2,650 mL distributed nationwide.

    Product
    CYANOCOBALAMIN FOR INTRAMUSCULAR OR SUBCUTANEOUS USE ONLY, Each mL contains: Cyanocobalamin 1000 mcg, , Also Contains: Benzyl Alcohol, Sodium Chloride, Water, Hydrochloric Acid, and/or Sodium Hydroxide, 30 mL, JOHN HOLLIS Pharmacist Inc, 110 20th Avenue N, Nashville, TN 37203, 6
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1397-2014·2014-06-25

    John W Hollis Inc Recalls Compounded Injectable Products Due to Sterility Concerns

    John W Hollis Inc is recalling specific lots of compounded injectable products containing papaverine, phentolamine, and alprostadil due to a lack of sterility assurance.

    Product
    Papaverine HCl 30 mg, Phentolamine Mesylate 1 mg, Alprostadil 20 mcg, a) 5 mL and b) 10 mL, JOHN HOLLIS Pharmacist, Inc, 110 20th Avenue N, Nashville, TN 37203, 615-327-3234
    Category
    Drug
    Distribution
    Distributed nationwide